Literature DB >> 2449972

Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

J R Glenney1, W S Chen, C S Lazar, G M Walton, L M Zokas, M G Rosenfeld, G N Gill.   

Abstract

Early events in ligand-induced endocytosis of the EGF receptor have been examined. A mutant EGF receptor devoid of intrinsic protein-tyrosine kinase activity bound EGF and dimerized normally yet failed to undergo ligand-induced internalization. Immunofluorescence microscopy revealed that receptors lacking kinase activity failed to undergo the ligand-induced internalization characteristic of receptors with kinase activity. Monoclonal anti-phosphotyrosine antibodies effectively inhibited phosphorylation of exogenous substrates in vitro and, when microinjected into cells containing active EGF receptors, prevented internalization of the receptor when cells were subsequently challenged with EGF. These results point to a crucial role for the kinase activity of the EGF receptor in the process of ligand-induced endocytosis of receptors, and imply that a phosphorylated substrate(s) is required.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449972     DOI: 10.1016/0092-8674(88)90405-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  57 in total

1.  Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.

Authors:  A L Boerger; S Snitkovsky; J A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

Review 3.  Epidermal growth factor receptor: elements of intracellular communication.

Authors:  S M Hernández-Sotomayor; G Carpenter
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

4.  Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation.

Authors:  Qian Wang; Greg Villeneuve; Zhixiang Wang
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

Review 5.  Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials.

Authors:  Prescott G Woodruff
Journal:  Proc Am Thorac Soc       Date:  2011-08

6.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

7.  Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.

Authors:  Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation.

Authors:  P Hoffman; C Carlin
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Recruitment of epidermal growth factor and transferrin receptors into coated pits in vitro: differing biochemical requirements.

Authors:  C Lamaze; T Baba; T E Redelmeier; S L Schmid
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.